Legend Biotech's total assets for Q2 2026 were $1.75B, an increase of 9.66% from the previous quarter. DE:9LB total liabilities were $521.32M for the fiscal quarter, a -17.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.